Efficacy and safety of an extended-release formulation of desloratadine and pseudoephedrine vs the individual components in the treatment of seasonal allergic rhinitis

Dykewicz, 1998, Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology, Ann Allergy Asthma Immunol., 81, 478, 10.1016/S1081-1206(10)63155-9 Juniper, 1994, Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials, J Allergy Clin Immunol., 93, 413, 10.1016/0091-6749(94)90349-2 Juniper, 1991, Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis, Clin Exp Allergy., 21, 77, 10.1111/j.1365-2222.1991.tb00807.x Settipane, 1999, Complications of allergic rhinitis, Allergy Asthma Proc., 20, 209, 10.2500/108854199778339053 Rachelefsky, 1999, National guidelines needed to manage rhinitis and prevent complications, Ann Allergy Asthma Immunol., 82, 296, 10.1016/S1081-1206(10)62612-9 Van Cauwenberg, 2000, Consensus statement on the treatment of allergic rhinitis, Allergy., 55, 116, 10.1034/j.1398-9995.2000.00526.x Baroody, 2000, Antiallergic effects of H1-receptor antagonists, Allergy., 55, 17, 10.1034/j.1398-9995.2000.00803.x Hadley, 1999, Evaluation and management of allergic rhinitis, Med Clin North Am., 83, 13, 10.1016/S0025-7125(05)70084-5 Meltzer, 2001, Efficacy and tolerability of once-daily 5 mg desloratadine, an H1-receptor antagonist, in patients with seasonal allergic rhinitis: assessment during the spring and fall allergy seasons, Clin Drug Invest., 21, 25, 10.2165/00044011-200121010-00004 Geha, 2001, Desloratadine: a new, nonsedating, oral antihistamine, J Allergy Clin Immunol., 107, 751, 10.1067/mai.2001.114239 Affrime, 2002, A pharmacokinetic profile of desloratadine in healthy adults including elderly, Clin Pharmacokinet., 41, 13, 10.2165/00003088-200241001-00003 Gupta, 2001, Oral bioavailability of desloratadine is unaffected by food, Clin Pharmacokinet., 41, 7 Banfield, 2002, Lack of clinically relevant interaction between desloratadine and erythromycin, Clin Pharmacokinet., 41, 29, 10.2165/00003088-200241001-00005 Banfield, 2002, Desloratadine has no clinically relevant electrocardiographic or pharmacodynamic interactions with ketoconazole, Clin Pharmacokinet., 41, 37, 10.2165/00003088-200241001-00006 Gupta, 2001, Pharmacokinetic and safety profile of desloratadine and fexofenadine when coadmin-istered with azithromycin: a randomized, placebo-controlled, parallel-group study, Clin Ther., 23, 451, 10.1016/S0149-2918(01)80049-7 Banfield, 2001, No drug interaction between fluoxetine and desloratadine, a new nonsedating once-daily antihistamine, J Allergy Clin Immunol., 107, S161 Khalilieh, 2002, Lack of an interaction with coadministration of desloratadine and cimetidine, Ann Allergy Asthma Immunol., 88, 110 Bachert, 2001, Decongestant efficacy of desloratadine in patients with seasonal allergic rhinitis, Allergy., 56, 14, 10.1034/j.1398-9995.2001.00102.x Nayak, 2001, Desloratadine reduces nasal congestion in patients with intermittent allergic rhinitis, Allergy., 56, 1077, 10.1034/j.1398-9995.2001.00082.x Corren, 1998, Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma [published erratum appears in, J Allergy Clin Immunol., 101, 792 1997, J Allergy Clin Immunol., 100, 781, 10.1016/S0091-6749(97)70274-4 Bronsky, 1995, Comparative efficacy and safety of a once-daily loratadine-pseudoephedrine combination versus its components alone and placebo in the management of seasonal allergic rhinitis, J Allergy Clin Immunol., 96, 139, 10.1016/S0091-6749(95)70001-3 Roman, 1993, Loratadine: a review of recent findings in pharmacology, pharmacokinetics, efficacy, and safety, with a look at its use in combination with pseudoephedrine, Clin Rev Allergy., 11, 89, 10.1007/BF02802295 Sussman, 1999, The efficacy and safety of fexofenadine HCl and pseudoephedrine, alone and in combination, in seasonal allergic rhinitis, J Allergy Clin Immunol., 104, 100, 10.1016/S0091-6749(99)70120-X Bertrand, 1996, Cetirizine and pseudoephedrine retard alone and in combination in the treatment of perennial allergic rhinitis: a double-blind multicentre study, Rhinology., 34, 91 Schenkel, 2002, Efficacy of once-daily desloratadine/pseudoephedrine for relief of nasal congestion, Allergy Asthma Proc., 23, 325